Antibiotice S.A. (BVB:ATB)

Antibiotice Balance Sheet

Financials in millions RON. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	3.08	9.94	2.68	1.81	1.73	2.11
Cash & Short-Term Investments	3.08	9.94	2.68	1.81	1.73	2.11
Cash Growth	-70.23%	270.87%	48.31%	4.66%	-18.18%	-66.64%
Accounts Receivable	350.34	294.6	275.39	221.13	196.51	269.76
Other Receivables	28.96	12.55	9.15	12.78	6.22	3.99
Receivables	379.3	307.15	284.54	233.91	202.73	273.75
Inventory	221.55	184.61	170.46	161.67	143.07	106.02
Prepaid Expenses	-	-	-	3.49	-	-
Other Current Assets	4.91	3.98	17.01	0.41	4.13	3.13
Total Current Assets	608.85	505.69	474.69	401.28	351.66	385.01
Property, Plant & Equipment	781.5	760.72	749.4	692.36	599.9	480.54
Other Intangible Assets	30.82	28.89	21.27	12.53	2.46	29.84
Long-Term Deferred Charges	47.74	41.06	33.9	33	30.29	-
Other Long-Term Assets	85.62	56.2	-	-	-	-
Total Assets	1,555	1,393	1,279	1,139	984.32	895.39

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	100.7	133.36	83.5	73.66	65.4	66.32
Accrued Expenses	28.44	14.99	34.27	9.69	2.87	8.4
Short-Term Debt	294.74	101.32	57.58	32.44	34.01	87.16
Current Income Taxes Payable	1.28	-	-	-	-	9.61
Current Unearned Revenue	0.52	0.52	3.83	0.73	0.6	3.47
Other Current Liabilities	61.61	0.18	55.88	73.95	33.81	24.17
Total Current Liabilities	487.29	250.36	235.06	190.47	136.69	199.14
Long-Term Debt	58.77	135.74	85.72	36.75	46.97	57.62
Long-Term Unearned Revenue	9.76	10.01	5.15	1.59	1.86	2.16
Long-Term Deferred Tax Liabilities	67.96	64.38	59.03	63.4	57.82	31.48
Other Long-Term Liabilities	-0	-0	-	-	-	-
Total Liabilities	623.78	460.49	384.95	292.21	243.34	290.4

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	67.13	67.13	67.13	67.13	67.13	67.13
Retained Earnings	667.16	662.75	613.23	554.41	476.09	-33.15
Comprehensive Income & Other	196.46	202.19	213.95	225.42	197.76	571.01
Shareholders' Equity	930.75	932.07	894.31	846.96	740.98	604.99
Total Liabilities & Equity	1,555	1,393	1,279	1,139	984.32	895.39

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	353.51	237.05	143.29	69.19	80.98	144.78
Net Cash (Debt)	-350.43	-227.11	-140.61	-67.38	-79.25	-142.67
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.52	-0.34	-0.21	-0.10	-0.12	-0.21
Filing Date Shares Outstanding	671.34	671.34	671.34	671.34	671.34	671.34
Total Common Shares Outstanding	671.34	671.34	671.34	671.34	671.34	671.34
Working Capital	121.56	255.33	239.64	210.81	214.97	185.87
Book Value Per Share	1.39	1.39	1.33	1.26	1.10	0.90
Tangible Book Value	899.93	903.19	873.04	834.44	738.52	575.15
Tangible Book Value Per Share	1.34	1.35	1.30	1.24	1.10	0.86
Land	204.79	204.79	204.79	204.79	203.67	189.93
Buildings	395.36	385.41	377.61	312.77	267.97	157.46
Machinery	378.83	372.91	344.5	296.48	271.21	234.38
Construction In Progress	63.54	34.82	20.57	42.67	9.09	64.71

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 3, 2026

Data Sources Report a data error